Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose methotrexate and Bexxar in untreated follicular lymphoma
NCT01389076Phase 2Terminated
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Jul 2011
- Primary completion
- Feb 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate in follicular lymphoma (FL), sponsored by University of Michigan Rogel Cancer Center. Started Jul 2011; status: terminated.
02
Drugs
methotrexate
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT01389076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01389076.